Antiandrogens
Aspirin
Bromhexine
Budesonide
Cannabidiol
Casirivimab/i..
Colchicine
Conv. Plasma
Curcumin
Diet
Ensovibep
Exercise
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Melatonin
Metformin
Molnupiravir
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Proxalutamide
Quercetin
Remdesivir
Sleep
Sotrovimab
Vitamin A
Vitamin C
Vitamin D
Zinc

Other
Feedback Home
Home   COVID-19 treatment studies for Diet  COVID-19 treatment studies for Diet  C19 studies: Diet  Diet   Select treatmentSelect treatmentTreatmentsTreatments
Antiandrogens (meta) Lactoferrin (meta)
Aspirin (meta) Melatonin (meta)
Bamlaniv../e.. (meta) Metformin (meta)
Bebtelovimab (meta) Molnupiravir (meta)
Bromhexine (meta) N-acetylcys.. (meta)
Budesonide (meta) Nigella Sativa (meta)
Cannabidiol (meta) Nitazoxanide (meta)
Casirivimab/i.. (meta) Paxlovid (meta)
Colchicine (meta) Peg.. Lambda (meta)
Conv. Plasma (meta) Povidone-Iod.. (meta)
Curcumin (meta) Probiotics (meta)
Diet (meta) Proxalutamide (meta)
Ensitrelvir (meta) Quercetin (meta)
Ensovibep (meta) Remdesivir (meta)
Exercise (meta) Sleep (meta)
Famotidine (meta) Sotrovimab (meta)
Favipiravir (meta) Tixagev../c.. (meta)
Fluvoxamine (meta) Vitamin A (meta)
Hydroxychlor.. (meta) Vitamin C (meta)
Iota-carragee.. (meta) Vitamin D (meta)
Ivermectin (meta) Zinc (meta)

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent: 
0 0.5 1 1.5 2+ Moderate/severe case 72% Improvement Relative Risk Moderate/severe case (b) 59% Case 19% Case (b) 23% c19early.com/dt Kim et al. Diet for COVID-19 Prophylaxis Favors healthy diet Favors control
Kim, 568 patient diet study: 72% fewer moderate/severe cases [p=0.02] and 19% fewer cases [p=0.24] https://c19p.org/kim4
copied to clipboard
Plant-based diets, pescatarian diets and COVID-19 severity: a population-based case–control study in six countries
Kim et al., BMJ Nutrition, Prevention & Health, doi:10.1136/bmjnph-2021-000272
7 Jun 2021    Source   PDF   Share   Tweet
Retrospective healthcare workers in six countries with exposure to COVID-19 patients, showing lower risk of moderate/severe COVID-19 with plant-based diets.
risk of moderate/severe case, 72.0% lower, OR 0.28, p = 0.02, higher quality diet 41, lower quality diet 527, adjusted per study, plant-based diets, multivariable, RR approximated with OR.
risk of moderate/severe case, 59.0% lower, OR 0.41, p = 0.05, higher quality diet 46, lower quality diet 522, adjusted per study, plant-based or pescatarian diets, multivariable, RR approximated with OR.
risk of case, 19.0% lower, OR 0.81, p = 0.24, higher quality diet 41, lower quality diet 527, adjusted per study, plant-based diets, multivariable, RR approximated with OR.
risk of case, 23.0% lower, OR 0.77, p = 0.14, higher quality diet 46, lower quality diet 522, adjusted per study, plant-based or pescatarian diets, multivariable, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Kim et al., 6/7/2021, retrospective, multiple countries, multiple regions, peer-reviewed, survey, 8 authors, study period 17 July, 2020 - 25 September, 2020.
All Studies   Meta Analysis
Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit